Exendin-4Fc fusion protein (Beijing Eastern Biotech)
Exendin-4Fc融合蛋白 (北京东方百泰生物科技)
Report date: 2024/02/21 13:45:06
Base Information
Drug NameExendin-4Fc fusion protein (Beijing Eastern Biotech)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaPhase 3 Clinical
Originator CompaniesBeijing Eastern Biotech Co Ltd
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A